Dana-Farber Cancer Care Collaborative
Dana-Farber/Brigham and Women’s Cancer Care Collaborative
Both the Dana-Farber Cancer Care Collaborative and the Dana-Farber/Brigham and Women's Cancer Care Collaborative serve a select group of hospitals that have demonstrated a commitment to excellence by meeting a wide range of standards and best practices in adult medical and/or radiation oncology.
To certify a hospital's membership, Dana-Farber clinicians and other specialists conduct an extensive and rigorous review of the hospital's oncology practices and procedures, including:
- Patient safety protocols
- Nursing and pharmacy practices
- Chemotherapy administration
- Information systems
Following review of their oncology operations, Collaborative members agree to implement key recommendations in order to meet Dana-Farber standards.
Benefits of Collaborative membership
Dana-Farber Collaborative membership enhances educational opportunities for member hospitals' staffs; offers opportunities for members to consult with medical specialists at Dana-Farber in Boston; and provides members with expedited access to Dana-Farber's main campus in Boston for their patients with complex cancers. Members can also take advantage of access to Dana-Farber support services, such as on-site specialty second opinion clinics, clinical trials, tumor board conferences, and physician lectures.
Dana-Farber is not responsible for the care provided at these locations.
Members of the Dana-Farber Cancer Care Collaborative - Adult Medical Oncology
- Berkshire Medical Center Cancer Center, Pittsfield, MA
- Cape Cod Hospital, Hyannis, MA
- Eastern Maine Medical Center (EMMC) Lafayette Family Cancer Center, Brewer, ME
- New England Cancer Specialists, Kennebunk, Scarborough, and Topsham, ME
- UMass Memorial Medical Center, Worcester, MA
Members of the Dana-Farber/Brigham and Women's Cancer Care Collaborative - Adult Medical and Radiation Oncology
Dana-Farber Cancer Institute and Lifespan Cancer Institute Strategic Alliance
Dana-Farber Cancer Institute and the Lifespan Cancer Institute in Rhode Island have created a strategic alliance to advance cancer treatment and research. Dana-Farber and Lifespan will support the expansion of clinical trials, access for Lifespan physicians to cancer-specific disease expertise for complex cases, and the launch of a new program to coordinate the treatment of bone marrow transplant patients, with transplants provided in Boston at Dana-Farber and care surrounding the transplant provided at Lifespan Cancer Institute in Providence. The two organizations will share patient information through their respective cancer-specific electronic health record systems and will use the same clinical trials management platform, resulting in better care coordination.
Strategic alliance member
Lifespan Cancer Institute, Rhode Island